Home›Stock Screener›Tejnaksh Healthcare

Tejnaksh Healthcare Share Price Today | Stock Price & Tejnaksh Healthcare Share Screener

TEJNAKSH Healthcare Services
Live Share Price BSE
₹14.70
▼ -0.29 (-1.93%)
2026-11-18 00:00:00

As of November 18, 2026, the live Tejnaksh Healthcare share price (BSE: TEJNAKSH) is ₹14.70, down 1.93% from the previous close, with shares trading between ₹14.62 and ₹16.66 in today's trading session, and a 52-week range of ₹11.18–₹17.21. Track Tejnaksh Healthcare networth to gauge the company's total market size. Use the Tejnaksh Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Tejnaksh Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹3 and net income of ₹1, with EBITDA of ₹1, an operating margin of 32.0% and a profit margin of 33.3%.

Tejnaksh Healthcare Market Cap ₹29.95 Cr.
TEJNAKSH P/E Ratio (TTM) 19.00
Tejnaksh Healthcare P/B Ratio 1.05
EPS (TTM) ₹0.61
Dividend Yield -
Debt to Equity 0.02
TEJNAKSH 52 Week High ₹17.21
Tejnaksh Healthcare 52 Week Low ₹11.18
Operating Margin 32.00%
Profit Margin 33.33%
TEJNAKSH Revenue (TTM) ₹3.00
EBITDA ₹1.00
Net Income ₹1.00
Total Assets ₹30.00
Total Equity ₹28.00

Tejnaksh Healthcare Share Price Chart

Track the current stock price of Tejnaksh Healthcare with an interactive chart. Analyse TEJNAKSH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Tejnaksh Healthcare stock quote in one place.

The quote of ₹14.70 sits between the 52-week low of ₹11.18 and the 52-week high of ₹17.21, and the latest session moved -1.93% from the previous close.

Tejnaksh Healthcare Company Profile - Fundamental Screener

Screen Tejnaksh Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TEJNAKSH shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE030T01027.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE030T01027

Tejnaksh Healthcare Balance Sheet Screener

Screen TEJNAKSH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹30, down from ₹30 in 2025.

Latest statistics put total assets at ₹30 and shareholder funds at ₹28, with a leverage ratio of 0.02.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 30 30 31 31 30 25 25 22 20 16
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 20 21 23 23 15 15 17 17 15 14

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 2 3 6 7 7 5 8 6 6 7
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 28 27 24 22 21 18 16 14 10 8
Share Capital 10 10 10 10 10 10 10 10 2 2
Reserves & Surplus 17 16 13 12 10 7 5 3 8 6

Tejnaksh Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Tejnaksh Healthcare income statement and profit fundamentals. Analyze TEJNAKSH quarterly results. Tejnaksh Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹3 and net profit was ₹1, equal to earnings per unit of ₹0.28, at an operating margin of 32%.

In that period expenses were ₹2, interest cost ₹0 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹3 and net profit of ₹0.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 3 3 3 3 3 3 3 3 4 3 3 3 3 3 3
Expenses 2 2 2 2 2 2 3 2 2 2 2 2 2 3 2

Operating Costs and Margins

EBITDA 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Operating Profit % 32.00% 26.00% 28.00% 26.00% 26.00% 23.00% 22.00% 36.00% 34.00% 34.00% 31.00% 34.00% 37.00% 17.00% 14.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 1 0 1 0 1 0 1 1 1 1 1 1 1 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 0 0 0 0 0 0 1 1 1 1 1 1 0 0
EPS 0.28 0.13 0.17 0.14 0.15 0.12 0.21 0.38 0.31 0.29 0.25 0.27 0.28 0.08 -0.01

Tejnaksh Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen TEJNAKSH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹2.

Over the same period, investing activities provided ₹0 and financing activities used ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 2 0 4 2 9 1 1 3 5 2
Investing Activities 0 4 -1 -1 -11 2 -1 -2 -3 -8

Financing and Net Cash

Financing Activities -1 -4 -2 -1 2 -3 0 -2 -1 6
Net Cash Flow 0 0 1 -1 0 0 0 -1 1 1

Tejnaksh Healthcare Shareholding Pattern Screener

See Tejnaksh Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Tejnaksh Healthcare promoter holding and ownership changes for TEJNAKSH on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 73.83%, foreign institutions 0.00%, domestic institutions 0.00% and the public 23.53%, spread across 4,341 shareholders.

The shareholder count was 4,341 in 2026-Sept, compared with 4,395 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 73.83% 73.83% 73.83% 73.83% 73.83% 73.83% 73.83% 73.83%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.53% 23.49% 23.58% 23.72% 23.73% 23.60% 23.58% 23.65%
Other Holding 2.64% 2.67% 2.59% 2.44% 2.44% 2.57% 2.58% 2.52%
Shareholder Count 4,341 4,395 4,414 4,452 4,550 4,552 4,493 4,496

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Tejnaksh Healthcare. Tejnaksh Healthcare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Tejnaksh Healthcare.

Tejnaksh Healthcare Stock Index Membership - Nifty & Sensex

See which indices include Tejnaksh Healthcare stock. Check TEJNAKSH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Tejnaksh Healthcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Tejnaksh Healthcare Market Events Screener - Corporate Actions

Get Tejnaksh Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Tejnaksh Healthcare stock events that may affect TEJNAKSH share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 12, 2026, with a record date of November 12, 2026.

It is followed by Annual General Meeting dated September 29, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-12 2026-11-12 Quarterly Result Announcement NA 4.41%
2026-09-29 2026-09-29 Annual General Meeting NA -5.38%
2026-08-13 2026-08-13 Quarterly Result Announcement NA 11.65%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 9.73%
2026-02-07 2026-02-07 Quarterly Result Announcement NA 6.30%
2025-11-08 2025-11-08 Quarterly Result Announcement NA -1.66%
2025-09-27 2025-09-27 Annual General Meeting NA -1.62%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -1.77%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 0.72%
2025-02-22 2025-02-22 Extraordinary General Meeting NA -2.79%
2025-02-11 2025-02-11 Quarterly Result Announcement NA -0.42%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -4.42%
2024-09-28 2024-09-28 Annual General Meeting NA -1.20%
2023-07-19 2023-07-19 Split 5:10 -1.33%
2018-04-26 2018-04-28 Bonus 36:10 25.55%

Tejnaksh Healthcare Competitors Screener - Peer Stocks Comparison

Screen TEJNAKSH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,732 53.90 25,420 15.58% 2,003 64.36
Max Healthcare Institute 99,764 71.20 8,536 18.82% 1,442 73.63
Manipal Health Enterprises 94,299 104.20 10,521 25.80% 917 58.01
Aster DM Quality Care 64,434 116.10 4,769 11.25% 427 61.53
Fortis Healthcare 60,823 57.00 9,179 16.93% 1,064 56.49
Narayana Hrudayalaya 39,002 45.00 7,996 43.43% 811 60.17
Global Health 38,919 62.80 4,509 19.56% 554 63.26
Dr. Lal Path Labs 33,466 57.20 2,864 12.11% 510 57.81
Krishna Institute of Medical Sciences 31,864 163.00 3,931 28.16% 242 65.46
Syngene International 17,572 95.70 3,809 2.56% 317 66.04

Tejnaksh Healthcare Company Announcements - News & Reports Screener

Screen TEJNAKSH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 15, 2026.

The next most recent announcements are dated November 15, 2026 and November 10, 2026.

Date Update Actions
2026-11-15 Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2026. -
2026-11-15 Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-11-10 Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window -
2026-11-02 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - International Recognition Of Dr. Ashish V. Rawandale Managing Director -
2026-10-24 Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Publication Of Scientific Validation Study Of Pflow™ In The Indian Journal Of Urology -
2026-10-24 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Announcement under Regulation 30 (LODR)-Change in Management -
2026-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-26 Closure of Trading Window -
2026-09-04 Reg. 34 (1) Annual Report. -
2026-09-04 Notice Of 19Th Annual General Meeting Of The Company To Be Held On 29Th September 2026 -
2026-08-13 Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30 June 2026. -
2026-08-13 Board Meeting Outcome for Outcome Of- Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-08 Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window -
2026-07-19 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -
2026-05-30 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-30 Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026. -
2026-05-30 Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹14.70, within a 52-week range of ₹11.18 to ₹17.21. The P/E ratio is 19.00 and the P/B ratio is 1.05, with earnings per unit of ₹0.61. Market capitalisation stands at ₹29.95 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.